|
Male/female
|
12/23
|
11/44
|
4/17
|
0.251
|
|
Age, mean ± SD (years)
|
70.5 ± 10.8
|
63.8 ± 11.5
|
59.8 ± 12.0
|
0.002
|
|
Weight, mean ± SD (Kg)
|
53.3 ± 9.5
|
52.9 ± 11.8
|
55.2 ± 10.1
|
0.501
|
|
BMI, mean ± SD
|
21.8 ± 3.5
|
21.7 ± 3.7
|
23.2 ± 4.9
|
0.344
|
|
RA duration, mean ± SD (years)
|
11.7 ± 12.5
|
14.1 ± 10.9
|
13.5 ± 11.2
|
0.144
|
|
MTX dose, mean ± SD (mg/week)
|
-
|
7.8 ± 2.4
|
7.2 ± 3.4(15/21)
|
-
|
|
ABT dose, mean ± SD (mg/4 week)
|
-
|
-
|
547.6 ± 127.9
|
-
|
|
Use of prednisolone, number of patients (%)
|
21 (60.0)
|
30 (54.5)
|
13(61.9)
|
0.798
|
|
Prednisolone dose, mean ± SD (mg/day)
|
6.06 ± 4.23
|
4.98 ± 2.97
|
5.04 ± 2.85
|
0.769
|
|
DAS28(CRP), mean ± SD
|
2.79 ± 1.17
|
2.61 ± 0.98
|
2.48 ± 1.31
|
0.565
|
|
SDAI, mean ± SD
|
9.03 ± 6.32
|
8.15 ± 7.33
|
8.32 ± 7.29
|
0.593
|
|
CDAI, mean ± SD
|
7.83 ± 5.40
|
7.46 ± 6.73
|
7.87 ± 6.54
|
0.721
|
|
IP (%)
|
6 (17.1)
|
7 (12.7)
|
3(14.3)
|
0.844
|
|
COPD (%)
|
3 (8.6)
|
1 (1.8)
|
2(9.5)
|
0.251
|
|
Smoking history (%)
|
10(28.6)
|
13(23.6)
|
6(28.6)
|
0.839
|
